Legal Representation
Attorney
B. Parker Livingston, Jr
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 10, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 31, 2001 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 28, 2000 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 25, 2000 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 30, 2000 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 30, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 7, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 6, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 24, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 20, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparation, specifically an intravenous formulation of adenosine for the treatment of acute myocardial infarction
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005